Polskie Radio runs a story making the point that Ozempic is approved for diabetes, not weight loss. Only the headline came through, so read on for the argument.
Recap by typeshit. Full story at www.polskieradio.pl.
A Facebook user criticizes telehealth marketing of tirzepatide and other GLP-1 services that targets new mothers, calling it predatory. One person's opinion.
Dr. Noc joined StarTalk to cover GLP-1 drugs, creatine, peptides and looksmaxxing. The full talk is out on YouTube and in podcast apps.
The obesity doctor says commenters once treated her early support for these medications as heresy. She adds that she saw their potential back in 2005.
A TikTok playlist collects GLP-1 updates from creator @stephaniemua1. There is no detail on what the videos cover beyond the playlist name.
Polskie Radio looks at a newer weight loss drug being framed as a successor to Ozempic. The material is thin, so tap through for which drug it is.
A short opinion post argues that speeding up weight loss with retatrutide shouldn't come ahead of actually getting healthier.
Loading…